30 related articles for article (PubMed ID: 36178086)
1. Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma.
Yoshida T; Sakai K; Kaibori M; Ishida M; Tanaka S; Kubo S; Nakai T; De Velasco MA; Matsushima H; Tsuta K; Sekimoto M; Nishio K
Oncol Lett; 2024 Mar; 27(3):124. PubMed ID: 38348389
[TBL] [Abstract][Full Text] [Related]
2. An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation.
Gubbiotti MA; Weinberg JS; Weathers SP; Dasgupta P; Tom MC; Aldape K; Quezado M; Abdullaev Z; Huse JT; Ballester LY
J Neuropathol Exp Neurol; 2024 Jan; 83(2):139-141. PubMed ID: 38164987
[No Abstract] [Full Text] [Related]
3. HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells.
Gonnella R; Arena A; Zarrella R; Gilardini Montani MS; Santarelli R; Cirone M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835344
[TBL] [Abstract][Full Text] [Related]
4. DNA damage triggers squamous metaplasia in human lung and mammary cells via mitotic checkpoints.
Juan LS; Freije A; Sanz-Gómez N; Jiménez-Matías B; Pleguezuelos-Manzano C; Sanz JR; de Diego E; Naranjo S; Clevers H; Gandarillas A
Cell Death Discov; 2023 Jan; 9(1):21. PubMed ID: 36681661
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol rescues cutaneous radiation-induced DNA damage via a novel AMPK/SIRT7/HMGB1 regulatory axis.
Jin Y; Liu X; Liang X; Liu J; Liu J; Han Z; Lu Q; Wang K; Meng B; Zhang C; Xu M; Guan J; Ma L; Zhou L
Cell Death Dis; 2023 Jan; 13(10):847. PubMed ID: 36587031
[TBL] [Abstract][Full Text] [Related]
6. JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms.
Arena A; Romeo MA; Benedetti R; Gilardini Montani MS; Cirone M
Exp Hematol; 2023; 119-120():28-41. PubMed ID: 36623719
[TBL] [Abstract][Full Text] [Related]
7. Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of ATR inhibitors.
Pan Y; Yang Y; Huang R; Yang H; Huang Q; Ji Y; Dai J; Qiao K; Tang W; Xie L; Yin M; Ouyang J; Ning S; Su D
Breast Cancer Res; 2022 Dec; 24(1):92. PubMed ID: 36539893
[TBL] [Abstract][Full Text] [Related]
8. Structure of the mouse H2A.X gene and physical linkage to the UPS locus on chromosome 9: assignment of the human H2A.X gene to 11q23 by sequence analysis.
Porcher C; Grandchamp B
Genomics; 1995 Jan; 25(1):312-3. PubMed ID: 7774939
[TBL] [Abstract][Full Text] [Related]
9. BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Piva F; Santoni M; Matrana MR; Satti S; Giulietti M; Occhipinti G; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Principato G; Cascinu S; Montironi R
Expert Rev Mol Diagn; 2015; 15(9):1201-10. PubMed ID: 26166446
[TBL] [Abstract][Full Text] [Related]
10. Genomics and clinical correlates of renal cell carcinoma.
Mitchell TJ; Rossi SH; Klatte T; Stewart GD
World J Urol; 2018 Dec; 36(12):1899-1911. PubMed ID: 30099580
[TBL] [Abstract][Full Text] [Related]
11. PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma.
He X; Xu J; Niu N; Xu G; Zhu H; Liu Z; Mou Y; Qian Z; Wang H; Hu J; Ma T; Ma J; Tao H
Clin Transl Med; 2022 Oct; 12(10):e1062. PubMed ID: 36178086
[TBL] [Abstract][Full Text] [Related]
12. PBRM1 loss is a late event during the development of cholangiocarcinoma.
Luchini C; Robertson SA; Hong SM; Felsenstein M; Anders RA; Pea A; Nottegar A; Veronese N; He J; Weiss MJ; Capelli P; Scarpa A; Argani P; Kapur P; Wood LD
Histopathology; 2017 Sep; 71(3):375-382. PubMed ID: 28394406
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.
Zhou Z; Huang D; Yang S; Liang J; Wang X; Rao Q
Pathol Oncol Res; 2022; 28():1610479. PubMed ID: 35928964
[No Abstract] [Full Text] [Related]
14. Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma.
Bihr S; Ohashi R; Moore AL; Rüschoff JH; Beisel C; Hermanns T; Mischo A; Corrò C; Beyer J; Beerenwinkel N; Moch H; Schraml P
Neoplasia; 2019 Feb; 21(2):247-256. PubMed ID: 30660076
[TBL] [Abstract][Full Text] [Related]
15. The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma.
Kim JY; Lee SH; Moon KC; Kwak C; Kim HH; Keam B; Kim TM; Heo DS
J Urol; 2015 Oct; 194(4):1112-9. PubMed ID: 25997916
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
